CLL (Chronic Lymphocytic Leukemia),Leukemia Addressing Ibrutinib AEs in Elderly CLL: Real-World Insights Feb 29, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Plasma CD150: CLL Patients’ Soluble Isoform Analysis Feb 27, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia MRD-Guided CLL Therapy: Ibrutinib-Venetoclax vs FCR Feb 16, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia CLL Risk: Second Malignancies in Treated vs Untreated Patients Feb 06, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia,Lymphoma,MCL (Mantle Cell Lymphoma) Pirtobrutinib: Continued Efficacy in Post-cbtki CLL/SLL Jan 22, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia High Remission Rates in CLL With Time-Limited BR-vr Jan 02, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Impact of Genomic Alterations on Fixed-Duration Ibr + Ven for CLL Dec 15, 2023
